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Abstract
Introduction and hypothesis Polypropylene is a material that
is commonly used to treat pelvic floor conditions such as
pelvic organ prolapse (POP) and stress urinary incontinence
(SUI). Owing to the nature of complications experienced by
some patients implanted with either incontinence or prolapse
meshes, the biocompatibility of polypropylene has recently
been questioned. This literature review considers the in vivo
response to polypropylene following implantation in animal
models. The specific areas explored in this review are material
selection, impact of anatomical location, and the structure,
weight and size of polypropylene mesh types.
Methods All relevant abstracts from original articles investi-
gating the host response of mesh in vivo were reviewed.
Papers were obtained and categorised into various mesh ma-
terial types: polypropylene, polypropylene composites, and
other synthetic and biologically derived mesh.
Results Polypropylene mesh fared well in comparison with
other material types in terms of host response. It was found
that a lightweight, large-pore mesh is the most appropriate
structure.
Conclusion The evidence reviewed shows that polypropylene
evokes a less inflammatory or similar host response when
compared with other materials used in mesh devices.
Keywords Biocompatibility . Host response .Mesh . Pelvic
organ prolapse . Polypropylene . Stress urinary incontinence
Introduction
Weakness of supporting tissues in the body, intended to main-
tain the integrity of bodily cavities, can result in the herniation
of organs beyond their original location. This phenomenon
can lead to altered function or damage to the organs and sur-
rounding structures. Stress urinary incontinence (SUI) and
pelvic organ prolapse (POP) are two common conditions that
occur in the pelvic floor region [1]. POP occurs when loss of
support of the vaginal wall causes one or more of the pelvic
organs to protrude into or beyond the vagina [2–5]. Stress
urinary incontinence is the involuntary leakage of urine upon
increased intraabdominal pressure [2, 6].
To restore structural integrity and/or function various ap-
proaches have been used. Conservative methods are often
attempted initially and, if unsuccessful, corrective surgery is
an option. Traditional surgical techniques have included su-
turing local tissue to the Cooper’s ligaments to support the
urethra in treating SUI and plication of the native tissue for
POP repair [1–3]. These procedures can be associated with
significant rates of recurrence of the original condition
[7–13]. In an attempt to address this problem the use of syn-
thetic materials were explored with incontinence and prolapse
meshes, which are designed to provide a longer lasting out-
come [3, 9, 14].
It should be noted that althoughmeshes for the treatment of
incontinence and prolapse have similarities in basic geometry,
they are configured differently according to their intended use.
The distinction between applications is important because re-
ported complication rates differ significantly for these two
device types [1, 15].
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There is considerable heterogeneity among devices avail-
able for use in tissue defect repair in POP and SUI. It has
therefore proven difficult for researchers to draw clear com-
parisons between these devices, and to identify which is the
most appropriate material for specific applications [11, 16].
Mesh constructs are traditionally classified into four groups
according to their pore size (see Table 1) [17]. This is a useful
classification since the pore size of meshes has long been
accepted as an important parameter for biocompatibility
[18]. The significance of pore size can be seen when host
responses to microorganisms are considered. The primary
function of the immune system is to defend the body against
invading pathogens. The cells involved in an immune re-
sponse are greater in size than certain pathogens that cause
infections; for example leukocytes average between 9–15 μm
and macrophages 16–20 μm whereas bacteria average 2 μm
in size. If the pore sizes in a mesh are less than that of relevant
immune cells then bacteria present could remain in the mesh
construct unchallenged thereby increasing the risk of infection
to the patient. The spaces in some multifilament constructs,
termed interstices, may act in a similar way to microporous
mesh and therefore increase the risk of infection [17, 19, 20].
However, the utility of this classification system has begun to
be questioned recently as mesh devices have continued to
evolve. Nevertheless, there is as yet no clear consensus regard-
ing an improved classification system [18].
A wide variety of materials have been used in medical
devices for tissue repair, from synthetic to biologically de-
rived, non-resorbable to resorbable, as demonstrated in
Fig. 1 [1]. Of all the materials that are currently in use for
mesh applications, polypropylene is the most common, and
is the most firmly established [21, 22]. Polypropylene was
first made in 1954 by Giulio Natta [23]. It is polymerised from
propylene, an ethylene with one methyl group attached, such
that in the polymer all the methyl groups face in the same
direction, classing it as an isotactic polymer. Its superiority
over other materials used in clinical mesh applications was
realised by Francis C. Usher in 1962, partly because of its
ability to be autoclaved [24]. In addition to the use of poly-
propylene in surgical meshes, this material can also be found
in other common medical applications such as sutures [14].
Polypropylene is an obvious option for pelvic floor repair
owing to its common use in abdominal wall and inguinal
hernia repair [25, 26].
Methods
A PubMed search for animal study articles published from
January 1990 to September 2015 was conducted using the
following search terms: Bmesh^, Btransvaginal^, Bvaginal^,
Bpelvic region^, Bpelvic floor^, pelvic organ prolapse^,
Bs t ress ur inary incont inence^, Bpolypropylene^,
Bbiomater ia l^, Btoxicology ,^ Bbiological safe ty ,^
Bbiocompatibility ,^ Bin vivo^, Banimal model^, Bhost
response^. Additional relevant publications were also selected
from the reference lists of the articles identified. Studies that
primarily focused on in vitro implantation were excluded.
Studies reporting on the biocompatibility or host response to
incontinence or prolapse mesh were selected. Studies compar-
ing treatments using polypropylene mesh with those using
mesh of any other material, or where no mesh was used at
all, were also selected. Non-comparative studies were exclud-
ed. A total of 585 different publications were identified in
PubMed. Titles and abstracts were reviewed by three re-
viewers for relevance before obtaining the full paper. Forty-
six papers were identified as being appropriate for inclusion in
the study. References of these papers were then scanned and
relevant papers were also included in the study. Selected stud-
ies were grouped together according to material type and an-
atomical location. Studies involving polypropylene were fur-
ther subdivided according to mesh structure.
Toxicology and biocompatibility
Owing to the nature of the complications experienced by some
patients implanted with devices for SUI and POP, and the fact
that polypropylene is the predominant material used, the tox-
icological properties and safety of this material have recently
been called into question [27].
A biological risk assessment of any medical device, includ-
ing incontinence and prolapse meshes, would have been con-
ducted by the manufacturer based on laboratory testing before
its first use in humans. This risk assessment would have in-
cluded a review of all relevant toxicity endpoints in relation to
the site and duration of exposure. Types of information used in
this risk assessment include: consideration of the chemical
nature of the materials, previous use in humans of the same
or similar materials in comparable situations and, if required,
results available from appropriate in vitro and/or in vivo bio-
logical tests, for example, those described in BS EN ISO
10993 series of standards to ensure that public health is not
put at risk [28].
Table 1 Amid’s classification of mesh constructs [17]
Type Pore size
I Completely macroporous: all pore sizes greater than 75 μm
II Totally microporous: pore size smaller than 10 μm in at
least one of the three dimensions
III Macroporous with multifilamentous components
IV Submicron pores
172 Int Urogynecol J (2017) 28:171–180
Data from clinical studies are an important consider-
ation in any risk assessment, particularly those that ad-
dress biological safety. However, none of the adverse ef-
fects that have been described with these procedures using
polypropylene has been found to correlate directly with
any toxicological property [29, 30]. To elucidate this, it
is possible to compare this situation with that of another
medical device type where a clinical outcome can be di-
rectly correlated with the toxicological properties of a
particular material: aseptic loosening of joint replacement
components. Joint replacements generate wear materials
that the immune system identifies as foreign. This process
results in bone loss and subsequent implant loosening,
which may in turn require revision of the component.
This process is termed osteolysis, and registry data have
shown this to be the second most common reason for
revision after infection [31]. Therefore, the extent of bone
loss caused by the bearing materials can be explored
using clinical studies. Because complications for SUI
and POP cannot be linked to any one toxicological prop-
erty, it is difficult to assess the toxicological properties of
these devices using clinical studies.
Toxicology is the study of adverse effects of substances on
living systems. This branch of science considers the inherent
potential of xenobiotics to induce adverse health effects and
whether under certain conditions of exposure that inherent
toxic potential will translate into a risk to human health.
Biocompatibility, often incorrectly used interchangeably with
toxicology, can only be demonstrated under a defined set of
circumstances [28]. Biocompatibility has been defined as Bthe
ability of a material to perform with an appropriate host re-
sponse in a specific application^ by Williams in 1987 and is
still a well-accepted definition today [32]. Biocompatibility is
dependent on a number of factors, including inter-individual
variations in tissue responses and factors related to procedure.
It is important to appreciate that it is possible for a device to
display a suitable response in one patient but not in another,
for example, capsular contracture, a complication reported in
some women who have received breast implants [28].
Any implanted material will evoke a host response to the
foreign body, often termed foreign body reaction, and this is
dependent upon patient susceptibility. This phenomenon is
unavoidable and is characterised by seven interrelated stages
post-implantation: injury, protein adsorption, acute inflamma-
tion, chronic inflammation, foreign body reaction, granulation
tissue formation and tissue encapsulation [33].
The authors’ initial review of the literature regarding pelvic
floor constructs concluded that host response was the main
consideration rather than inherent toxicity of materials.
Animal studies are useful for understanding the adverse ef-
fects directly related to the material. They enable
standardisation of experimental parameters such as environ-
mental conditions, material exposure and technique [28].
Therefore, this review focuses on the literature relating to the
in vivo response to polypropylene and other materials used in




Any foreign material implanted in the body has the potential
to elicit a host response. The immune responses mounted by
different individuals can differ significantly, despite the same
materials and surgical techniques having been used [34]. This
section discusses in vivo studies comparing polypropylene
with three other synthetic materials used in tissue repair:
polytetrafluoroethylene (PTFE), polyester and polyethylene
terephthalate. Polypropylene is widely reported to be more
biocompatible and has been shown to elicit the lowest level
of inflammatory response compared with other polymeric ma-
terials such as nylon, polyacrylonitrile and polyethylene tere-
phthalate [35, 36].
A review of the literature has shown that the host response
to polypropylene is comparable with, or better than, the re-
sponse to polyester-, PTFE- and expanded PTFE-based
meshes in animal models. Novotny et al. found that polypro-
pylene was comparable with PTFE in terms of biocompatibil-
ity when a sample of mesh was implanted intraperitoneally in
New Zealand white rabbits. At 90 days post-implantation, the
number of inflammatory cells and granuloma formation were
seen to be similar [37]. All other studies reviewed by this
group found comparable results. Hengirmen et al. reported
that PTFE elicited a more pronounced foreign body reaction
Fig. 1 Summary of mesh types
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compared with polypropylene 12-week post-implantation in a
rat abdominal wall. The authors concluded that polypropylene
is a more suitable mesh material than PTFE for abdominal
repair [38]. This finding was supported by Harrell et al. when
expanded PTFE mesh was compared with polypropylene in a
rabbit model following implantation over a longer period of
time [39]. Bleichrodt et al. took this one stage further and
measured the outcome of both these mesh materials when
implanted in a contaminated environment in a rat model.
The surgical site was contaminated using a rat faeces suspen-
sion 1 week before implantation of the mesh under investiga-
tion. It was found that hernia recurrence was significantly
greater in the expanded PTFE group compared with the poly-
propylene group. The authors concluded that expanded PTFE
is unsuitable for use in the repair of infected abdominal walls
[40]. This is a potentially important finding when selecting a
material suitable for use in the pelvic floor region, as it has
beenwidely reported that there is an increased risk of infection
when materials are introduced via the vaginal route [41, 42].
Polypropylene-based meshes also fared well when
compared with polyester-based meshes. Zinther et al.
found that polyester elicited a more pronounced host re-
sponse than polypropylene meshes, coated with collagen
and polyvinylidene fluoride respectively, in the peritone-
um of sheep 2 years after implantation [43]. The authors
also found that where polyester meshes were implanted
there was greater shrinkage than was observed with poly-
propylene [43]. Orenstein et al. compared polypropylene
with both polyester and expanded PTFE meshes im-
planted in a mouse model. Similar to the findings above,
the authors found that polypropylene induced a less pro-
nounced foreign body reaction compared with the other
two materials and polyester performed less well with re-
gard to biocompatibility, showing a more marked foreign
body reaction. Foreign body reaction in this study was
measured in terms of the number of foreign body giant
cells around the mesh fibres [44].
Boulanger et al. compared polypropylene mesh with
another synthetic polymer, polyethylene terephthalate,
fixed onto the peritoneum of female pigs [45]. The poly-
ethylene terephthalate mesh generated a more intense in-
flammatory reaction compared with polypropylene-based
meshes in terms of higher macrophage and lymphocyte
cell count 72 days post-implantation. Tissue integration
was also less favourable in terms of the presence of
collagen fibre organisation, fibroblasts, and vascularisa-
tion [45].
Polypropylene composites
In an attempt to modify host responses to synthetic meshes, a
range of composite materials have been examined [1]. Three
classes of new composite material meshes, all incorporating
polypropylene, are reviewed in this section: polypropylene
with expanded PTFE, polypropylene with a resorbable con-
stituent and polypropylene with a biologically derived
component.
Expanded PTFE was selected as an additional biomaterial
thought to reduce inflammation and impede undesirable tissue
ingrowth that could lead to adhesion formation owing to its
microporous structure [46]. Marcondes et al. and Harrell et al.
found that polypropylene mesh was comparable with a com-
posite of polypropylene with expanded PTFE in terms of for-
eign body reaction in rabbit models [25, 39, 48]. Marcondes et
al. determined using histological analyses that the inflamma-
tory reactions in the two groups were similar 20 days after
implantation [47]. As indicated above, a comparable result
was reported by Harrell et al. 4 months after implantation in
terms of inflammatory cell count and tissue in-growth, despite
this study using one of the earliest meshes, a heavyweight
mesh [39].
Resorbable components have begun to be incorporated
into constructs in an attempt to improve the handling
characteristics of polypropylene mesh [25, 39, 48].
Polypropylene mesh with a resorbable component was
not found to improve biocompatibility compared with
polypropylene when implanted in the abdomen and blad-
der of a rat model and the abdomen of rabbit and pig
models [46, 47, 49–53]. In a recent study conducted by
Utiyama et al., polypropylene mesh was compared with
polypropylene with a resorbable polyglecaprone film im-
planted into the abdomen of Wistar rats. No significant
differences in the host’s response were identified in terms
of the percentage of fibrosis, adhesions, shrinkage and
various inflammatory cell counts [53]. Boulanger et al.
noted that a partially resorbable mesh with a polyglactin
component elicited an intense inflammatory reaction
when implanted onto the peritoneum of pigs compared
with polypropylene meshes [45]. Discussions on whether
this composite fulfils all other essential requirements for
use as a mesh is outside the scope of this review.
Another variant that has been investigated is the use of
biologically derived substances as a coating on polypro-
pylene mesh thought to mitigate the host’s foreign body
response. This in turn would improve in-growth and re-
duce erosion and mesh exposure [54]. Similar to the find-
ings above, the testing of these components in vivo has
found that this technology does not offer an improvement
in biocompatibility compared with polypropylene.
Huffaker et al. found that polypropylene mesh coated with
porcine collagen elicited a similar mild foreign body re-
action and low-grade fibrotic response to uncoated poly-
propylene when implanted into the vagina of New
Zealand white rabbits for 12 weeks [55]. A similar result
was achieved for both materials by Pierce et al. 90 days
after implantation in the abdominal wall of rats [56]. Van’t
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Riet et al. found that polypropylene was less susceptible
to infection than collagen-coated polypropylene mesh fol-
lowing implantation in the abdominal wall of rats for
30 days [57]. Despite advances in these composite mate-
rials, the above findings demonstrate that polypropylene
remains comparable with or superior to polypropylene
composite mesh with regard to host responses when im-
planted in experimental animal models.
Biologically derived meshes
The use of biologically derived materials has been investigat-
ed in the last decade with the aim of reducing complications
associated with pelvic floor repair, such as erosion and
dyspareunia [58]. Biologically derived materials are classed
as acellular collagen matrices and are often derived from the
dermis, pericardium, small intestinal submucosa or urinary
bladder matrix of bovine or porcine origin [1, 22, 59]. These
materials can undergo crosslinking, the formation of excessive
intra- and inter-molecular bonds, to improve the longevity of
the material [59]. Despite their use in other medical device
applications, previously published work has concluded that
non-crosslinked biological matrices are inappropriate because
of their rapid degradation in situ [1, 59, 60]. In contrast, they
found that crosslinked matrices may be more appropriate ow-
ing to a longer degradation profile, despite the increased risk
of encapsulation [1, 59, 60]. However more evidence is need-
ed to support these findings. Polypropylene mesh was found
to have a longer-lasting and more supportive structure com-
pared with porcine-derived matrices implanted in the abdo-
men of rats and rabbits, attributed to the fibrosis associated
with the normal foreign body response to polypropylene [38,
61]. Krambeck et al. also found that polypropylene induced
less inflammation and eosinophil infiltrate after 12 weeks
when implanted in rabbits [61]. In addition to these findings,
longer term studies in a rabbit model have also shown poly-
propylene in a favourable light compared with an acellular
collagen mesh. Christodoulou et al. found that polypropylene
had superior mechanical properties when mesh was implanted
for 9 months in the rabbit abdomen [62]. Despite using a
crosslinked material, Pierce et al. found that crosslinked por-
cine dermis degraded after 9 months following implantation in
both the vagina and abdomen of rabbits [58]. This degradation
was accompanied by a greater, and more intense, inflamma-
tory reaction than polypropylene. This study also investigated
the rate of erosion. Erosion has been defined as the superficial
destruction of a surface by friction, pressure, ulceration, or
trauma [19]. The authors reported a higher erosion rate in
the polypropylene group (27 %) compared with crosslinked
porcine dermis (15 %) [58]. A similar finding was reported by
Fan et al., who found that crosslinked urinary bladder matrix
was associated with less erosion compared with polypropyl-
ene after 12 weeks’ implantation in the rabbit vagina [22]. In
both studies no erosion was found when these materials were
implanted in the abdomen of rabbits [22, 58]. In contrast to the
above studies, polypropylene mesh fared well in terms of
graft-related complications compared with crosslinked acellu-
lar collagen matrix derived from bovine pericardium im-
planted into the vaginal region of sheep for 180 days. Lower
rates of contractility and calcification were observed with
polypropylene mesh [60]. In conclusion, analyses of the liter-
ature reports available have revealed that polypropylene is
more appropriate in terms of the mechanical requirements of
pelvic floor repair. Over time, the biologically derived mate-
rials discussed above are prone to degradation, leaving behind
a weak structure that increases the risk of recurrence when
used for tissue repair. Overall, polypropylene has also fared
well in terms of host response compared with several types of
biologically derived materials. Recently Shi et al. investigated
the biocompatibility of decellularised human amniotic mem-
brane as a potential mesh material, with favourable results
[63]. However further studies would need to be carried out
to investigate if this is a viable option.
Fully resorbable meshes
All foreign materials are associated with a chronic inflamma-
tory reaction, which is variable depending on specific factors,
including patient characteristics. Therefore, implanting for-
eign materials will never be completely risk free. A material
that degrades over time is not associated with the same level of
risk as the inflammatory reaction would normally be expected
to resolve once complete degradation had occurred. The cur-
rent view is that the only material type that truly meets the
definition of biocompatibility is one that resorbs fully over
time [1].
Mesh-related complications due to host response issues
have proven particularly difficult to manage in certain pa-
tients. This has led to research into the feasibility of using fully
resorbable meshes for tissue repair [64]. The use of this tech-
nology has been explored as far back as the 1980s, with ini-
tially poor results for long-term mechanical support and the
resultant high recurrence rates [65]. Resorbable meshes have
been shown to have a comparable acute inflammatory re-
sponse to polypropylene [45]. However, none of the types of
resorbable meshes investigated have resulted in adequate tis-
sue incorporation. As a result of this, resorbable meshes were
deemed unsatisfactory when prolonged tensile strength is re-
quired, such as that needed for the treatment of SUI and POP
[53, 65, 66]. Recent improvements have been reported by
Hjort et al. using a novel resorbable material, namely a copol-
ymer of glycolide, lactide and trimethylene. Following im-
plantation in the abdomen of a sheepmodel, strong connective
tissue was observed after 36 months, with none of the animals
showing recurrence at the end of the study. The authors stated
that this is the world’s first long-term resorbable mesh and
Int Urogynecol J (2017) 28:171–180 175
takes a minimum of 6 months to degrade, thereby allowing
sufficient time for a collagen matrix to form [67]. Similarly, de
Tayrac et al. demonstrated that the use of polylactic acid
(PLA) could be a promising alternative material for long-
lasting pelvic floor repair because of its slower degradation
rate, which is attributed to the small fibres. A 12-month in
vitro test showed that PLA mesh maintains a reduction of
30 % in its mechanical strength for the first 6 months [64].
In addition to this, PLA mesh was shown to have comparable
mechanical properties with polypropylene mesh 3 months af-
ter implantation in rats [68]. However, these promising find-
ings would need to be supported by long-term in vivo testing
[69].
Further investigation into the biocompatibility of resorba-
ble meshes is required to validate the findings above and to
understand fully the prospect of using resorbable materials in
tissue repair applications that require mechanical support.
Structure and size of mesh
Pore size and weight
As discussed above, the in vivo responses to polypropylene
have been shown to be at least comparable with all other
materials used in mesh applications. In view of this, the vari-
ations in the structure of polypropylene meshes have been
investigated to determine if there are any biological response
differences. The effects of pore size and weight have been
analysed following implantation in rodent, pig and rabbit
models. Studies in the literature reveal that the lighter the
polypropylene mesh per square metre, the less pronounced
the foreign body response observed [19]. A similar outcome
was observed when the pore size was increased across the
mesh. These effects have been observed when several bio-
compatibility endpoints were measured, namely: granuloma
formation, scar bridging formation, in addition to inflamma-
tory cell and mediator expression [18, 39, 44, 52, 70–72]. The
impact of pore size on scar formation was investigated by
Klinge et al. when implanting polypropylene mesh in the ab-
domen of rats for 90 days. A heavy-weight, small-pore mesh
was associated with intense chronic inflammation accompa-
nied by extensive scar bridging. Conversely, the lower-weight,
large-pore mesh exhibited scarring similar to the control
group. The authors state that pore size is a significant factor
in the tissue’s response and the overall biocompatibility of
polypropylene mesh [18].
Feola et al. found a difference in the biomechanical prop-
erties of the vagina when implanting meshes of different
weights in nonhuman primates. The most pronounced adverse
outcome was observed following implantation of the heaviest
polypropylene mesh. The heaviest mesh had the greatest neg-
ative impact on both active and passive mechanical properties,
where a greater reduction in vaginal contractility and tissue
stiffness of the vagina was found [73]. This is thought to be
due to the effect of stress shielding, a phenomenon that occurs
when the stiffer material blocks or reduces the adjacent mate-
rial from the full impact of physiological loading [73, 74].
This idea is supported in a study by Liang et al., who also
implanted meshes of different weights in nonhuman primates.
The heaviest polypropylene mesh induced the highest level of
matrix-degrading enzymes compared with the lighter polypro-
pylene meshes [75].
There is a lack of evidence relating to the mechanical re-
quirements for a prolapse repair. However, it is accepted that
the requirements are greater than that necessary for an abdom-
inal defect repair. Understanding these requirements fully is
crucial in determining how far it is possible to reduce the
weight of a material and for it still to perform its necessary
functions. Work carried out by Cobb et al. pointed to the
feasibility of reducing the weight of a mesh beyond that cur-
rently considered to be a light-weight construct. It has been
found that the lightest mesh tested still far exceeded the burst
strength of native abdominal wall tissue when implanted into a
porcine ventral hernia model. Furthermore, there was no sig-
nificant difference in the mean burst loads between the medi-
um (590 N) and lightweight (576 N) meshes. The fact that the
burst load for the heavyweight mesh (1,200 N) was much
greater, suggests a plateau effect between the mid- and light-
weight meshes [76]. This indicates that it may be possible to
further reduce the weight of a pelvic floor construct. However,
caution must be exercised, as demonstrated by Ozog et al.,
who attempted to implant an ultra-lightweight polypropylene
mesh of 7.6 g/m2 into the abdomen of rabbits. The authors
deemed the handling characteristics of this mesh inappropriate
because of folding upon insertion, which was not observed
with the heavier mesh [77].
Monofilament versus multifilament
In addition to the above observations, Krause et al. investigat-
ed differences in biological responses between type I
(monofilament) and type III (monofilament with a
multifilamentous component) meshes. The authors found that
when a type III mesh was implanted into the abdominal wall
of rats for 3 months the resultant inflammatory and fibrous
reactions were more pronounced and persistent compared
with those of type I mesh [78]. This is thought to be due to
the interstices created in multifilament constructs, which is an
important consideration because, as already discussed, small
pores are thought to increase the likelihood of bacteria being
inaccessible to immunocompetent cells. This was demonstrat-
ed by Díaz-Godoy et al. when polypropylene meshes of vary-
ing pore sizes were tested in a contaminated rabbit model. It
was found that the larger the pore size, the fewer the number
of animals that were found to have infection at the end of the
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study. In fact, none of the animals implanted with the meshes
with the largest pore size displayed clinical signs of infection,
or positive biological cultures on the last day of the study [79].
The potential clinical relevance to humans of the above
findings was demonstrated by Badiou et al. when cases of
erosion were found to be significantly higher in animals show-
ing signs of infection, in terms of increased bacteria count
around the mesh, compared with animals without infection.
These comparative studies were conducted using mesh that
was sutured to the surface of the abdominal wall of female
Wistar rats. Following closure of the surgical site a suspension
of Escherichia coli was injected around the mesh [80]. This
supports the current view that infection is a significant risk
factor in the development of erosion [19].
Size of mesh
Pierce et al. found that the erosion rate was significantly re-
duced when smaller pieces of graft material were used. The
rate decreased from 27 % to 10 % for smaller polypropylene
mesh when implanted in the vagina of rabbits and analysed
after 9 months [58]. This finding was replicated in a sheep
model by Manodoro et al., where it was reported that poly-
propylene mesh, when reduced in area from 50 mm2 to
35 mm2, resulted in a decrease in erosion rate from 30 % to
0 % when implanted in the vagina [81]. These findings sug-
gest that, all other factors being equal, the amount of material
might be directly proportional to the erosion rate, a known
complication in the presence of an intense foreign body re-
sponse [19, 77].
The impact of anatomical location
To explore whether differences exist between the placement of
mesh in the abdominal and the vaginal regions, investigators
have examined the impact of anatomical location on host re-
sponses using the New Zealand white female breeder rabbit.
This animal is seen as a more suitable model than rodents
when conducting vaginal surgery research [22]. A few studies
have shown that the placement of mesh in the vaginal region
results in a more pronounced inflammatory reaction compared
with abdominal placement [22, 58, 82]. Fan et al. observed an
erosion rate of 67 % and evidence of necrosis when polypro-
pylene mesh was placed in the vagina of rabbits for 12 weeks,
compared with no erosion observed when placed in the abdo-
men. However, the same authors advise caution when
interpreting these results, as there was difficulty modelling
the vagina because of the small operating space, an issue not
experienced in abdominal surgery modelling [82]. In support
of this, Huffaker et al. found that no erosion occurred follow-
ing implantation of lightweight monofilament polypropylene
meshes in the vagina of New Zealand white rabbits after
12 weeks [55]. In a more recent study investigating host re-
sponse differences between the vagina and abdomen, Endo et
al. implanted biologically derived mesh into sheep for
180 days. It was found that a greater number of graft-related
complications were observed with mesh at the vaginal site
compared with the abdominal site. In particular, the contrac-
tion rate was three times higher in the vagina than in the
abdomen. There was also a marked difference in the occur-
rence of degradation between the groups. Degradation of the
acellular collagen matrix coincided with an abundance of for-
eign body giant cells. It is not yet known if this degradation
process is a faster or more vigorous process at the vagina [59].
Despite the paucity of studies in this area, the current find-
ings discussed above suggest that the pelvic region might be
more susceptible to complications than the abdominal region
in relation to heightened host response. The potential clinical
relevance is not yet understood. The very high erosion rate
reported in the study by Fan et al. is not typically observed in
humans and this could indicate interspecies differences [22].
Conclusion
Pelvic organ prolapse and stress urinary incontinence are two
pelvic floor disorders that are often treated with the use of
synthetic materials. One of the first materials used in the con-
struction of mesh devices, and one that is still predominantly
used today, is polypropylene. Other materials have also been
evaluated for their use in mesh applications ranging from al-
ternative synthetic to biologically derived materials. The use
of resorbable components has also been explored, either as an
addition to the polypropylene or as a fully resorbable device.
This review has investigated the suitability of polypropyl-
ene as an implantable material by comparing the in vivo host
responses of polypropylene in animals with other material
types. This has revealed that polypropylene evokes a less in-
flammatory or similar host response compared with other syn-
thetic materials and polypropylene composite meshes. This is
a useful finding, as animal studies are a good indicator of how
a material may behave in humans. Promising biocompatibility
outcomes have been observed with the use of biologically
derived and fully resorbable meshes. However, both these
types of material currently lack the mechanical strength re-
quired for long-lasting repair, thereby increasing the risk of
recurrence of the original problem.
Selecting the most appropriate material for a given proce-
dure requires a risk-based analysis to be conducted by surgical
staff. This should include consideration of the likelihood of
recurrence and the risk of complications.
A review of the structural differences within polypropylene
meshes points favourably towards using a light-weight mesh
with large pores. Small pore sizes have been associated with a
higher infection rate, attributed to the difference in size
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between immune cells and pathogens. This outcome is
thought to be significant as infection is a factor that increases
the risk of erosion, a known complication with mesh devices.
In addition to this, lighter-weight, more porous mesh allows
for more normal loading on the surrounding tissue, leading to
improved tissue in-growth.
It is known that the surface area of material implanted is
proportional to the host response produced. The cause of this
is multifactorial and includes patient and material factors. The
impact of anatomical location has only been researched by a
small number of authors. Despite this, the current evidence
suggests that the pelvic region is more susceptible to
exhibiting host response issues than the abdominal region.
However, anatomical location and size of mesh are often fac-
tors that cannot be adjusted when repairing a prolapse in the
pelvic floor region, which may in turn lead to a higher level of
complications.
The available evidence suggests that there might be scope
for reducing the weight of the mesh beyond that currently
considered to be light-weight, yet retaining the desired me-
chanical properties. This may contribute to reducing the
amount of material against which a host response could be
mounted and the level of inflammation. However, given the
multifactorial nature of complications, the overall impact of
doing this may currently be difficult to determine.
Further work is required to understand the differences in
host response between mesh device placements in the pelvic
compared with the abdominal region. Interspecies differences
will need to be explored in greater detail in an attempt to find
the most suitable animal model.
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